Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 12:56 AM
NCT ID:
NCT07285993
Eligibility Criteria:
Inclusion Criteria:
* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
* Females; Age \> 18 years of age
* Diagnosis of invasive lobular breast cancer, with pathologically confirmed metastatic disease.
* ECOG performance status 0-2
* No planned change in anticancer therapy between FDG and FAPI PET scans
Exclusion Criteria:
* Patients who are pregnant or lactating
* Patients who cannot undergo PET/CT scanning
* Patients with total serum bilirubin or serum creatinine \> 1.5 times the upper limit of normal
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07285993
Study Brief:
Protocol Section:
NCT07285993